Ashwagandha Withania Somnifera

Abstract Ashwagandha (Withania Somnifera) has been extensively studied for its adaptogenic and neuro-modulatory properties, offering potential benefits for mental health conditions such as depression, anxiety, and insomnia. This review summarizes the mechanisms of action, including hypothalamic–pituitary–adrenal (HPA) axis regulation, γ-aminobutyric acid (GABA) and serotonin modulation, antioxidant activity, and neuroplasticity enhancement. Clinical evidence supports its role in reducing perceived stress, improving sleep quality, and enhancing cognitive performance, particularly in populations exposed to chronic stress, such as students, high-demand professionals, business owners, and menopausal women. Evidence-based dosage ranges and safety profiles are also discussed to guide targeted nutritional interventions.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-08-15
DOI
https://doi.org/10.5281/zenodo.16882624
Primary Topic
Phytochemicals and Medicinal Plants
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ashwagandha Withania Somnifera

Zenodo (CERN European Organization for Nuclear Research)
Phytochemicals and Medicinal Plants
article

Ashwagandha Withania Somnifera

article en

Abstract

Abstract Ashwagandha (Withania Somnifera) has been extensively studied for its adaptogenic and neuro-modulatory properties, offering potential benefits for mental health conditions such as depression, anxiety, and insomnia. This review summarizes the mechanisms of action, including hypothalamic–pituitary–adrenal (HPA) axis regulation, γ-aminobutyric acid (GABA) and serotonin modulation, antioxidant activity, and neuroplasticity enhancement. Clinical evidence supports its role in reducing perceived stress, improving sleep quality, and enhancing cognitive performance, particularly in populations exposed to chronic stress, such as students, high-demand professionals, business owners, and menopausal women. Evidence-based dosage ranges and safety profiles are also discussed to guide targeted nutritional interventions.

Zenodo (CERN European Organization for Nuclear Research)
KeyW (United States) (US)
Zero hunger
Openalex Percentile: Top 41%
Phytochemicals and Medicinal Plants
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.